| scholarly article | Q13442814 |
| P2093 | author name string | Jiang Ke | |
| Mou Jing | |||
| P2860 | cites work | The optimal timing of antihypertensive medication administration for morning hypertension in patients with cerebral infarction. | Q51356422 |
| C-Reactive Protein Levels in the First Three Hours After Acute Cerebral Infarction | Q82623079 | ||
| Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction | Q83152515 | ||
| Edaravone alleviates delayed neuronal death and long-dated cognitive dysfunction of hippocampus after transient focal ischemia in Wistar rat brains | Q83222513 | ||
| Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study | Q85034903 | ||
| The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease | Q27015129 | ||
| Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke | Q34769939 | ||
| Massive cerebral infarction | Q36110093 | ||
| Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction | Q36955000 | ||
| Efficacy and safety of human urinary kallidinogenase injection for acute ischemic stroke: a systematic review | Q38092911 | ||
| Protective effect of edaravone against Alzheimer's disease-relevant insults in neuroblastoma N2a cells. | Q39249288 | ||
| Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil | Q39827634 | ||
| Use of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients: Evaluation of Clinical Outcomes | Q41635141 | ||
| Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro | Q41837296 | ||
| Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat. | Q42507233 | ||
| Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization--prospective evaluation at diffusion-weighted MR imaging | Q44450888 | ||
| Edaravone may be an efficacious adjunctive therapeutic agent for decompression sickness: an editorial perspective | Q46042646 | ||
| Survivin is involved in the anti-apoptotic effect of edaravone in PC12 cells | Q46118701 | ||
| Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture | Q46622475 | ||
| P433 | issue | 2 | |
| P921 | main subject | edaravone | Q335099 |
| cerebral infarction | Q1209150 | ||
| P304 | page(s) | 155-158 | |
| P577 | publication date | 2016-05-26 | |
| P1433 | published in | Biomedical Reports | Q26853995 |
| P1476 | title | Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction | |
| P478 | volume | 5 |
| Q92979181 | Effects of Urinary Kallidinogenase on NIHSS score, mRS score, and fasting glucose levels in acute ischemic stroke patients with abnormal glucose metabolism: A prospective cohort study |
| Q90379367 | Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery |
| Q41449078 | Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension |
| Q55177578 | Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases. |
Search more.